Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-11

Clinical Trial Update: A Study to Compare the Safety and Imaging Pattern of Cyclotron-produced Technetium (CTC) vs. Generator-produced Technetium (G-PERT) in People With Thyroid Disorders Who Need Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing safety and imaging patterns of cyclotron-produced Technetium versus generator-produced Technetium in patients with thyroid diso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cyclotron-produced Technetium (technetium-99m produced by cyclotron)
  • generator-produced Technetium (technetium-99m from generator)

Snippet

Sponsor: University of Alberta | Conditions: Thyroid Gland Diseases | Phase 3 | Status: COMPLETED